Arkolith/Insider Trading/CINC/Form 4

Parmar Kush

10% OwnerCinCor Pharma, Inc. (CINC) · full profile →Form 4 · filed Jan 13, 2022
Net Buying
Open-Market Buys
$7.5M
Open-Market Sells
$0
Net Open-Market Flow
$7.5M
Transactions
7
4 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 11, 2022Conversion(C)3.7M——3.7M
Jan 11, 2022Conversion(C)184K——184K
Jan 11, 2022Buy(P)158K$16.00$2.5M3.8M
Jan 11, 2022Buy(P)313K$16.00$5.0M496K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 11, 2022Conversion(C)10.0M—$00
Jan 11, 2022Conversion(C)2.5M—$00
Jan 11, 2022Conversion(C)625K—$00

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-003205) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML